- Home
- IVA vs SBGI Comparison
IVA vs SBGI Comparison
Compare IVA & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- SBGI
- Stock Information
- Founded
- IVA 2011
- SBGI 1986
- Country
- IVA France
- SBGI United States
- Employees
- IVA N/A
- SBGI N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- SBGI Broadcasting
- Sector
- IVA Health Care
- SBGI Industrials
- Exchange
- IVA Nasdaq
- SBGI Nasdaq
- Market Cap
- IVA 769.0M
- SBGI 886.6M
- IPO Year
- IVA 2020
- SBGI 1995
- Fundamental
- Price
- IVA $5.27
- SBGI $13.18
- Analyst Decision
- IVA Strong Buy
- SBGI Buy
- Analyst Count
- IVA 7
- SBGI 5
- Target Price
- IVA $16.57
- SBGI $20.80
- AVG Volume (30 Days)
- IVA 211.2K
- SBGI 351.6K
- Earning Date
- IVA 09-29-2025
- SBGI 11-05-2025
- Dividend Yield
- IVA N/A
- SBGI 7.59%
- EPS Growth
- IVA N/A
- SBGI N/A
- EPS
- IVA N/A
- SBGI 0.74
- Revenue
- IVA $19,929,536.00
- SBGI $3,481,000,000.00
- Revenue This Year
- IVA N/A
- SBGI N/A
- Revenue Next Year
- IVA N/A
- SBGI $9.50
- P/E Ratio
- IVA N/A
- SBGI $17.78
- Revenue Growth
- IVA N/A
- SBGI 8.11
- 52 Week Low
- IVA $2.11
- SBGI $11.89
- 52 Week High
- IVA $7.98
- SBGI $18.46
- Technical
- Relative Strength Index (RSI)
- IVA 47.78
- SBGI 41.39
- Support Level
- IVA $4.96
- SBGI $12.66
- Resistance Level
- IVA $5.34
- SBGI $13.61
- Average True Range (ATR)
- IVA 0.74
- SBGI 0.34
- MACD
- IVA 0.07
- SBGI 0.02
- Stochastic Oscillator
- IVA 23.86
- SBGI 41.27
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.